1. Home
  2. LTRN vs BEAT Comparison

LTRN vs BEAT Comparison

Compare LTRN & BEAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LTRN
  • BEAT
  • Stock Information
  • Founded
  • LTRN 2013
  • BEAT 2015
  • Country
  • LTRN United States
  • BEAT United States
  • Employees
  • LTRN N/A
  • BEAT N/A
  • Industry
  • LTRN Biotechnology: Pharmaceutical Preparations
  • BEAT Retail: Computer Software & Peripheral Equipment
  • Sector
  • LTRN Health Care
  • BEAT Technology
  • Exchange
  • LTRN Nasdaq
  • BEAT Nasdaq
  • Market Cap
  • LTRN 49.9M
  • BEAT 57.6M
  • IPO Year
  • LTRN 2020
  • BEAT 2021
  • Fundamental
  • Price
  • LTRN $4.00
  • BEAT $1.65
  • Analyst Decision
  • LTRN Strong Buy
  • BEAT Buy
  • Analyst Count
  • LTRN 1
  • BEAT 1
  • Target Price
  • LTRN $25.00
  • BEAT $8.00
  • AVG Volume (30 Days)
  • LTRN 177.8K
  • BEAT 75.4K
  • Earning Date
  • LTRN 11-06-2025
  • BEAT 11-06-2025
  • Dividend Yield
  • LTRN N/A
  • BEAT N/A
  • EPS Growth
  • LTRN N/A
  • BEAT N/A
  • EPS
  • LTRN N/A
  • BEAT N/A
  • Revenue
  • LTRN N/A
  • BEAT N/A
  • Revenue This Year
  • LTRN N/A
  • BEAT N/A
  • Revenue Next Year
  • LTRN N/A
  • BEAT $19.35
  • P/E Ratio
  • LTRN N/A
  • BEAT N/A
  • Revenue Growth
  • LTRN N/A
  • BEAT N/A
  • 52 Week Low
  • LTRN $2.55
  • BEAT $0.91
  • 52 Week High
  • LTRN $6.12
  • BEAT $3.48
  • Technical
  • Relative Strength Index (RSI)
  • LTRN 43.96
  • BEAT 50.03
  • Support Level
  • LTRN $3.89
  • BEAT $1.66
  • Resistance Level
  • LTRN $4.58
  • BEAT $1.81
  • Average True Range (ATR)
  • LTRN 0.28
  • BEAT 0.13
  • MACD
  • LTRN -0.04
  • BEAT -0.03
  • Stochastic Oscillator
  • LTRN 18.44
  • BEAT 6.96

About LTRN Lantern Pharma Inc.

Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.

About BEAT Heartbeam Inc.

HeartBeam Inc is a medical technology company is focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.

Share on Social Networks: